TIDMEIH
RNS Number : 3200S
EIH PLC
29 September 2017
29 September 2017
EIH PLC
("EIH" or the "Company")
Interim Results
The Company announces its interim results for the six months
from 1 January 2017 to 30 June 2017. A copy of this announcement
will shortly be available for inspection at www.eihplc.co.uk.
Chairman's Statement
The Company made a profit of US$0.6m for the six month period to
30 June 2017 (six month period to 30 June 2016: loss US$0.5m), and
therefore earnings per share for the six month period to 30 June
2017 was 0.92 cents (six month period to 30 June 2016: loss per
share 0.85 cents). The reason for the profit generated in the
current period is due to the US$0.8m increase in fair value of the
Company's investment in Evolvence India Fund PCC.
The unaudited net assets of the Company as at 30 June 2017 were
valued at US$25.9m and therefore net asset value ("NAV") per share
at that date was 40.2 cents based on 64,500,002 ordinary shares in
issue (31 December 2016 NAV per share: 43.3 cents).
During the period under review, on 21 February 2017, the Company
made a capital distribution of 4 cents per share to shareholders of
the Company registered as at 17 February 2017, equivalent to
approximately US$2.58m.
While the NAV per share decreased by 7.2% in the period under
review, after adjusting for the capital distribution of 4.0 cents
per share made in February 2017, the Company's NAV rose by 2.1% in
the period.
The Company has separately announced today that it intends to
make a further capital distribution of 1.5 cents per share to
shareholders of the Company registered as at 20 October 2017,
equivalent to approximately US$0.97m.
Total operating costs during the period were US$0.23m, or 1.3%
below the comparable prior year figure. In addition, the Company
paid certain annual management fees and expenses to Evolvence India
Fund PCC ("EIF") in respect of its commitments. These costs are
embedded in the capital account of EIF and do not appear in the
Company's statement of comprehensive income.
The Company's investment portfolio comprises the following
(based on unaudited values as at 30 June 2017):
Table 1. Investments Capital Commitment Capital Invested Capital Fair value Fair Value
Distribution Adjustment
--------------------- ------------------- ----------------- -------------------- -------------------- -----------
US$'000 US$'000 US$'000 US$'000 US$'000
Fund Investments
(equity)
Evolvence India Fund
PCC 45,120 45,120 (26,970) 1,097 19,247
Direct Investments
(equity)
EIF Co Invest VII
(RSB Group) 6,970 6,970 (29) (1,430) 5,511
52,090 52,090 (26,999) (333) 24,758
--------------------- ------------------- ----------------- -------------------- -------------------- -----------
Further details on the Company's investment portfolio are set
out below and in Note 5 to the interim financial statements.
EIF
As at 30 June 2017 the Company had US$18.2m invested in EIF
(capital called less refund capital contributions), equivalent to
28.1 cents per share. At the reporting date the Fair Value
(unaudited) of the Company's investment in EIF was US$19.2m,
equivalent to 29.8 cents per share, representing a 1.06 x multiple
over cost. EIF is now fully drawn down.
In local currency terms, the S&P BSE SENSEX Indian stock
market index advanced by 16.1% during the period in review. It is
also noted that the Indian Rupee ("INR") strengthened by 5.1% in
value against the US Dollar during the period in review.
Against this backdrop EIF's underlying private equity funds
performed reasonably such that on the basis of beginning and end
period values, and adjusting for drawdowns and distributions made
during the period, the fair value of EIF's underlying funds
increased by approximately 7.8% in US Dollar terms, while their
value increased by approximately 2.6% in INR terms. On the same
basis of measurement, the value of EIF's direct investments
increased by approximately 1.0% in US Dollar terms, while in INR
terms a decrease of approximately 3.9% was experienced.
EIF's private equity fund exposure is weighted towards funds
with vintages of 2006 and later. The four funds of these vintages
comprise 76.8% of EIF's private equity fund weighting. The
remaining six funds, with a 23.2% weighting, are all 2004 and 2005
vintages. EIF's three largest funds constitute 73.0% of EIF's
private equity fund weighting. These funds are Jacob Ballas India
Fund III (Growth / PIPE category), JMF India Fund I (Growth
category) and HI-REF International LLC (Real Estate category). The
majority of EIF's ten underlying private equity funds have fully
drawn down their committed capital from EIF, and EIF's remaining
commitments are concentrated in one fund, HI-REF International LLC
Fund. During the period under review, EIF received net
distributions from all except three of its funds, while drawdowns
were extremely limited.
The Directors have reviewed certain underlying financial
information provided to us by EIF's Investment Manager and we
remain confident that as EIF's underlying portfolio matures and
further realisations are achieved, further cash distributions will
be received by the Company.
EILSF Co-invest I / Gland Pharma Limited ("Gland")
At the beginning of the period under review and calculated on a
"look through" basis, the Company retained an approximate US$2.0m
interest in EILSF Co-invest I (held through EIF Co Invest X and
EIF) representing its share of the Gland proceeds retained to
address any potential contingencies. The final distribution
amounting to US$1.4m comprising largely of the Company's share of
its interest in EILSF Co-invest I occurred in January 2017.
RSB Group ("RSB")
RSB is a large automotive components group based in Pune with a
multi-product portfolio comprising of propeller shafts, gears,
axles, machined engine components, trailers and construction
equipment parts. The Company's direct investment in RSB is held
through EIF Co Invest VII. The shareholders in EIF Co Invest VII
are the Company and EIF, which invested US$7.0m and US$10.0m
respectively, for a total investment of US$17.0m. No fees are
payable on the Company's investment in EIF Co Invest VII, while the
Company's indirect investment in RSB (through its interest in EIF)
attracts standard management and carried interest fee arrangements.
Through the above arrangements, and on a look-through basis, the
Company has a total of US$6.9m invested in RSB (at cost) compared
to the US$7.0m invested in RSB through EIF Co Invest VII.
Through the above arrangements, and on a look-through basis, the
fair value of the Company's total interest in RSB is 10.7 cents per
share; while the fair value of the Company's direct interest in RSB
(held through EIF Co Invest VII) is 8.5 cents per share. These
values represent a 0.8 times multiple over cost. The Fair Value of
the Company's interest in RSB is based on a valuation performed by
EIF's investment manager.
Table 2. Investments (Fair Values) As per LP reports RSB Pro-forma
(EIF)
------------------------------------ ------------------ -------- ----------
US$'000 US$'000 US$'000
Fund Investments
EIF (PE funds) 11,730 11,730
EIF (direct investments) 7,065 (1,424) 5,641
EIF (other) 452 452
Direct Investments
RSB Group 5,511 1,424 6,935
24,758 - 24,758
------------------------------------ ------------------ -------- ----------
Table 2 extracts the Company's "look through" interest in RSB
(from EIF) and adds it to the Company's direct interest in RSB
(held by EIF Co Invest VII). On this basis, 28.0% of the Company's
Financial Assets at Fair Value (US$6.9m, equivalent to 10.7 cents
per share), is accounted for by its interest in RSB on an
underlying pro-forma basis.
Table 2 further shows that 47.4% of the Company's Financial
Assets at Fair Value is accounted for by its interests in EIF's ten
PE fund investments, and a further 22.8% by its interests in EIF's
direct investments (excluding RSB).
Board changes
On 26 June 2017, Paul Garnett resigned, and Brett Miller was
appointed, a director of the Company. On 30 June 2017, Andrew Baker
resigned, and Tim Shepherd was appointed, the secretary of the
Company.
Other matters
At the date of signing this report, the Company holds US$1.12m
in net cash balances, equivalent to 1.74 cents per share.
As a Board we will continue to manage operating costs carefully.
Our objective remains to realise assets at the appropriate time and
value, and to return the proceeds, less expenses, to our
shareholders.
On behalf of the Board of Directors, I thank all Shareholders
for their support.
Respectfully yours,
Rhys Cathan Davies
29 September 2017
For further information, please contact:
EIH PLC
Rhys Davies
Tel: +41 (0) 79 620 0215
Nplus1 Singer Advisory LLP (Nominated Adviser)
James Maxwell / Alex Laughton-Scott
+44 (0)20 7496 3000
EIH PLC
UNAUDITED STATEMENT OF COMPREHENSIVE INCOME
FOR THE SIX MONTHSED 30 JUNE 2017
For the period For the period
from 1 January from 1 January
2017 to 2016 to
30 June 2017 30 June 2016
Note US$'000 US$'000
------------------------------------- ------ ---------------- ----------------
Income
Interest income on
cash balances 1 1
Loss on disposal of
investments at fair (4) -
value through profit
or loss
Fair value movement
on investments at fair
value through profit
or loss 5 824 (318)
Net investment income/(expenditure) 821 (317)
------------------------------------- ------ ---------------- ----------------
Expenses
Administrative expenses (103) (107)
Legal and other professional
fees (100) (98)
Audit fees (22) (20)
Other expenses/income (2) (5)
Total operating expenses (227) (230)
------------------------------------- ------ ---------------- ----------------
Profit/(loss) before
taxation for the period 594 (547)
Income tax expense - -
Profit/(loss) after
taxation for the period 594 (547)
------------------------------------- ------ ---------------- ----------------
Other comprehensive - -
income
------------------------------------- ------ ---------------- ----------------
Total comprehensive
income/(expenditure)
for the period 594 (547)
------------------------------------- ------ ---------------- ----------------
Basic and fully diluted
earnings/(loss) per
share (US cents) 6 0.92 (0.85)
------------------------------------- ------ ---------------- ----------------
The accompanying notes form an integral part of these interim
financial statements.
EIH PLC
UNAUDITED STATEMENT OF FINANCIAL POSITION
AS AT 30 JUNE 2017
As at 30 As at 31
June December
2017 2016
Note US$'000 US$'000
------------------------------ ----- --------- ----------
Non-current assets
Financial assets at
fair value through
profit or loss 5 24,758 26,645
------------------------------- ----- --------- ----------
Total non-current
assets 24,758 26,645
------------------------------- ----- --------- ----------
Current assets
Trade and other receivables 37 18
Cash and cash equivalents 1,208 1,314
------------------------------- ----- --------- ----------
Total current assets 1,245 1,332
------------------------------- ----- --------- ----------
Total assets 26,003 27,977
=============================== ===== ========= ==========
Equity
Issued share capital 1,265 1,265
Share premium 22,402 24,982
Retained earnings 2,261 1,667
------------------------------- ----- --------- ----------
Total equity 25,928 27,914
------------------------------- ----- --------- ----------
Current liabilities
Trade and other payables 75 63
Total current liabilities 75 63
------------------------------- ----- --------- ----------
Total liabilities 75 63
------------------------------- ----- --------- ----------
Total equity and liabilities 26,003 27,977
=============================== ===== ========= ==========
The accompanying notes form an integral part of these interim
financial statements.
EIH PLC
UNAUDITED STATEMENT OF CHANGES IN EQUITY
FOR THE SIX MONTHSED 30 JUNE 2017
Share Share Retained Total
capital premium earnings
US$'000 US$'000 US$'000
US$'000
----------------------- --------- --------- ---------- ---------
Balance at 1
January 2016 1,265 26,595 4,063 31,923
Total comprehensive
income
Loss for the
period - - (547) (547)
Transactions
with owners of
the company recorded
directly in equity
Return of capital - - - -
Balance at 30
June 2016 1,265 26,595 3,516 31,376
----------------------- --------- --------- ---------- ---------
Balance at 1
January 2017 1,265 24,982 1,667 27,914
Total comprehensive
income
Profit for the
period - - 594 594
Transactions
with owners of
the company recorded
directly in equity
Return of capital - (2,580) - (2,580)
Balance at 30
June 2017 1,265 22,402 2,261 25,928
----------------------- --------- --------- ---------- ---------
The accompanying notes form an integral part of these interim
financial statements.
EIH PLC
UNAUDITED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS TO 30 JUNE 2017
For the For the
period from period from
1 January 1 January
2017 to 2016 to
30 June 30 June
2017 2016
Note US$'000 US$'000
Cash flows from operating
activities
Profit/(loss) before taxation 594 (547)
Adjustments:
Loss on disposal of investments
at fair value through
profit or loss 4 -
Fair value movement on
investments at fair value
through profit or loss 5 (824) 318
Interest income on cash
balances (1) (1)
Operating loss before
working capital changes (227) (230)
Increase in trade and
other receivables (19) (6)
Increase in trade and
other payables 12 18
--------------------------------- ----- -------------- --------------
Net cash used in operations (234) (218)
Net cash used in operating
activities (234) (218)
--------------------------------- ----- -------------- --------------
Cash flows from investing
activities
Interest income on cash
balances 1 1
Proceeds from disposal
of investment 1,352 -
Capital distribution received 5 1,355 723
Net cash generated by
investing activities 2,708 724
--------------------------------- ----- -------------- --------------
Cash flows from financing
activities
Return of capital (2,580) -
--------------------------------- ----- -------------- --------------
Net cash used in financing
activities (2,580) -
--------------------------------- ----- -------------- --------------
Net (decrease)/increase
in cash and cash equivalents (106) 506
Cash and cash equivalents
at 1 January 1,314 2,114
--------------------------------- ----- -------------- --------------
Cash and cash equivalents
at 30 June 1,208 2,620
================================= ===== ============== ==============
The accompanying notes form an integral part of these interim
financial statements.
Notes to the Unaudited Interim Results
For the six months ended 30 June 2017
1 The Company
EIH PLC (formerly Evolvence India Holdings plc) was incorporated
and registered in the Isle of Man under the Isle of Man Companies
Act 1931-2004 on 10 November 2006 as a public company with
registration number 118297C. On 28 March 2011 the Company
re-registered under the Isle of Man Companies Act 2006 with
registration number 006738V.
Pursuant to a prospectus dated 19 March 2007 there was a placing
of up to 65,000,000 Ordinary Shares of GBP0.01 each. The number of
Ordinary Shares in issue immediately following the placing was
65,000,002. The shares of the Company were admitted to trading on
the Alternative Investment Market of the London Stock Exchange
("AIM") following the close of the placing on 23 March 2007. The
Company purchased 500,000 of its own shares for US$0.60 each on 30
September 2011.
The Company's agents perform all significant functions.
Accordingly, the Company itself has no employees.
2 Duration
The Company currently does not have a fixed life but the Board
considers it desirable that Shareholders should have the
opportunity to review the future of the Company at appropriate
intervals. Accordingly, at the annual general meeting of the
Company in 2018 a resolution will be proposed that the Company
ceases to continue as presently constituted. Shareholders holding
at least fifty one per cent of the shares must vote in favour of
this resolution for it to be passed. If the resolution is not
passed, a similar resolution will be proposed at every third annual
general meeting of the Company thereafter. If the resolution is
passed, the Directors will be required, within 3 months of the
resolution, to formulate proposals to be put to Shareholders to
reorganise, unitise or reconstruct the Company or for the Company
to be wound up.
3 Significant accounting policies
The principal accounting policies adopted in the preparation of
the financial statements are set out below.
3.1 Basis of presentation
These interim financial statements have been prepared in
accordance with International Financial Reporting Standard (IFRS)
IAS 34: Interim Financial Reporting. They do not include all of the
information required for full annual financial statements and
should be read in conjunction with the financial statements of the
Company for the year ended 31 December 2016. The interim financial
statements are unaudited.
The accounting policies adopted in the preparation of the
interim consolidated financial statements are consistent with those
followed in the preparation of the Company's annual financial
statements for the year ended 31 December 2016.
Notes to the Unaudited Interim Results
For the six months ended 30 June 2017 (continued)
3.2 Investments at fair value through profit or loss
Investments are designated as financial assets at fair value
through profit or loss. They are measured at fair value with gains
and losses recognised through profit or loss.
The Company's investments at fair value through profit and loss
comprise funds and co-investment vehicles, where fair value is
estimated by the Directors to be the Company's share of net asset
value per latest financial results reported by the underlying fund
administrator.
3.3 Segment reporting
The Company has one segment focusing on maximising total returns
through investing in an Indian private equity portfolio of
investments. No additional disclosure is included in relation to
segment reporting, as the Company's activities are limited to one
business and geographic segment.
4 Net asset value per share
The unaudited net asset value per share as at 30 June 2017 is
40.2 cents per share based on 64,500,002 ordinary shares in issue
as at that date (31 December 2016: 43.3 cents per share based on
64,500,002 ordinary shares).
5 Financial assets at fair value through profit or loss
The objective of the Company is to make indirect investments in
Indian private equity funds and companies via Mauritian based
investment funds and to also co-invest directly in certain
portfolio companies of the underlying funds. As at 30 June 2017,
the investment portfolio comprised the following assets:
Investments Capital Commitment Capital Invested Capital Fair value Fair Value
(Unlisted) Distribution Adjustment
--------------------- ------------------- ----------------- -------------------- -------------------- -----------
US$'000 US$'000 US$'000 US$'000 US$'000
Fund Investments
(equity)
Evolvence India Fund
PCC 45,120 45,120 (26,970) 1,097 19,247
Direct Investments
(equity)
EIF Co Invest VII
(RSB Group) 6,970 6,970 (29) (1,430) 5,511
52,090 52,090 (26,999) (333) 24,758
--------------------- ------------------- ----------------- -------------------- -------------------- -----------
Notes to the Unaudited Interim Results
For the six months ended 30 June 2017 (continued)
5 Financial assets at fair value through profit or loss (continued)
The fair value of the Company's investments has been estimated
by the Directors with advice from Evolvence India Advisors Inc. The
movement in investments during the period was as follows:
30 June 31 December
2017 2016
US$'000 US$'000
Fair value brought forward 26,645 29,922
Disposal of investments at
fair value (1,356) -
Capital distributions (1,355) (1,356)
Movement in fair value 824 (1,921)
Fair value at period/year
end 24,758 26,645
----------------------------- --------- ------------
The outstanding capital commitments as at 30 June 2017 were
US$nil (31 December 2016: US$nil).
Evolvence India Fund PCC (EIF)
Evolvence India Fund PCC, a Protected Cell Company formed under
the laws of Mauritius having limited liability, is a private equity
fund of funds with a co-investment pool, focusing primarily on
investments in India. The fund size of EIF is US$250m, of which
approximately two-thirds have been invested in different private
equity funds (including growth capital, mezzanine and real estate
funds) with significant focus on India, and the balance has been
invested in co-investment opportunities, primarily in Indian
companies or companies with significant operations in India. The
fund investments of EIF include Baring India Private Equity Fund
II, IDFC Private Equity Fund II, India Value Fund II (Formerly GW
Capital), Leverage India Fund, New York Life Investment Management
India Fund II, Ascent India Fund, JM Financial India Fund I, HI-REF
International LLC Fund, NYLIM Jacob Ballas India Fund III and IDFC
Private Equity Fund III.
Valuation basis
The fair value of the investment in EIF is based on the
Company's share of the net assets of EIF at 30 June 2017 per its
results as reported by the underlying fund administrator. The
financial statements of EIF are prepared under IFRS, with all
investments stated at fair value. The valuation of the investment
portfolio of EIF has been performed by its investment manager at 30
June 2017. The investment portfolio comprises investments in
private equity funds, where fair value is based on reported net
asset values, and co-investments in private companies where fair
values are based on valuation techniques.
Notes to the Unaudited Interim Results
For the six months ended 30 June 2017 (continued)
5 Financial assets at fair value through profit or loss (continued)
EIF Co Invest VII
The Company has invested US$7m in RSB Group through a Special
Purpose Vehicle (SPV), EIF Co Invest VII. RSB Group is a leading
manufacturer of automotive components and construction aggregates.
The fair value of the investment in Co Invest VII is based on the
Company's share of the net assets of Co Invest VII at 30 June 2017
per its financial results as reported by the underlying fund
administrator. The financial statements of EIF Co Invest VII are
prepared under IFRS, with all investments stated at fair value. The
underlying valuation of RSB Group, which is unlisted, is based on
the trading multiples of RSB's comparable group and the application
of a liquidity discount thereto.
EIF Co Invest X
The Company held its interest in Gland Pharma Limited through an
SPV, EIF Co Invest X. EIF Co Invest X sold its interest in Gland
Pharma Limited during the year ended 31 December 2014, but retained
an amount of the sale proceeds to address any possible
contingencies. The Company received its final distribution of
US$1.4m in respect of this interest on 24 January 2017.
6 Earnings/(loss) per share
Basic and fully diluted earnings/(loss) per share is calculated
by dividing the profit/(loss) attributable to equity holders of the
Company by the weighted average number of ordinary shares in issue
during the period:
30 June 30 June
2017 2016
'000 '000
Profit/(loss) attributable
to equity holders of the
Company (US$) 594 (547)
Weighted average number of
ordinary shares in issue 64,500 64,500
Basic earnings/(loss) per
share (cents per share) 0.92 (0.85)
----------------------------- -------- --------
There are no dilutive potential ordinary shares in issue,
therefore there is no difference between the basic and fully
diluted earnings per share for the period.
7 Subsequent events
The Company intends to make a further capital distribution of
1.5 cents per share to shareholders of the Company registered as at
20 October 2017, equivalent to approximately US$0.97m.
This information is provided by RNS
The company news service from the London Stock Exchange
END
IR SEIFMUFWSEFU
(END) Dow Jones Newswires
September 29, 2017 12:17 ET (16:17 GMT)
Eih (LSE:EIH)
Historical Stock Chart
From May 2024 to Jun 2024
Eih (LSE:EIH)
Historical Stock Chart
From Jun 2023 to Jun 2024